MiRNA-based therapeutics for Ageing: MiRNA-181b suppresses the expression of a bio-marker of ageing INK4a/p16 via down regulation of its target gene, 2/September/2014, 5.44 am

MiRNA-based therapy to inhibit Metastatic progression: MiRNA-7 suppresses the expression of a stem cell protein Lin-28 via down regulation of its target gene, TA-p73, 2/September/2014, 0.5.36 am
September 2, 2014
Vitamin-based therapy for DM: 1,25-dihydroxyvitamin D3 increases the expression of a positive regulator of insulin transcription, NeuroD1 via down regulation of its target gene, 2/September/2014, 06.23 am
September 2, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., MiRNA-based therapeutics for Ageing: MiRNA-181b suppresses the expression of a bio-marker of ageing INK4a/p16 via down regulation of its target gene, 2/September/2014, 0.5.44 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org.

* Research cooperation

Significance: This study suggests that pharmacological formulations encompassing “MiRNA-181b inhibitor” may be used to inhibit ageing process.

Comments are closed.